https://ir.ibioinc.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_cb42441534fd6349452c8f98bd96594f/ibioinc/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.ibioinc.com/news-events/press-releases/detail/257/ibio-received-regulatory-clearance-to-initiate-its-phase-1-clinical-trial-of-ibio-600-in-australia Wed, 08 Apr 26 07:00:00 -0400 https://ir.ibioinc.com/news-events/press-releases/detail/257/ibio-received-regulatory-clearance-to-initiate-its-phase-1-clinical-trial-of-ibio-600-in-australia https://ir.ibioinc.com/news-events/press-releases/detail/256/ibio-to-provide-an-update-on-cardiopulmonary-program-targeting-pulmonary-hypertension-associated-with-heart-failure-with-preserved-ejection-fraction-ph-hfpef Mon, 16 Mar 26 16:30:00 -0400 https://ir.ibioinc.com/news-events/press-releases/detail/256/ibio-to-provide-an-update-on-cardiopulmonary-program-targeting-pulmonary-hypertension-associated-with-heart-failure-with-preserved-ejection-fraction-ph-hfpef https://ir.ibioinc.com/news-events/press-releases/detail/255/ibio-reports-preclinical-body-composition-data-from-obese-non-human-primates-treated-with-ibio-610-a-potential-first-in-class-treatment-for-fat-selective-weight-loss Mon, 09 Mar 26 07:00:00 -0400 https://ir.ibioinc.com/news-events/press-releases/detail/255/ibio-reports-preclinical-body-composition-data-from-obese-non-human-primates-treated-with-ibio-610-a-potential-first-in-class-treatment-for-fat-selective-weight-loss https://ir.ibioinc.com/news-events/press-releases/detail/254/ibio-to-participate-in-upcoming-investor-conferences Tue, 24 Feb 26 07:00:00 -0500 https://ir.ibioinc.com/news-events/press-releases/detail/254/ibio-to-participate-in-upcoming-investor-conferences https://ir.ibioinc.com/news-events/press-releases/detail/253/ibio-reports-q2-fiscal-year-2026-financial-results-and-provides-corporate-update Tue, 10 Feb 26 16:05:00 -0500 https://ir.ibioinc.com/news-events/press-releases/detail/253/ibio-reports-q2-fiscal-year-2026-financial-results-and-provides-corporate-update https://ir.ibioinc.com/news-events/press-releases/detail/252/ibio-announces-26-million-private-placement Fri, 09 Jan 26 07:00:00 -0500 https://ir.ibioinc.com/news-events/press-releases/detail/252/ibio-announces-26-million-private-placement https://ir.ibioinc.com/news-events/press-releases/detail/251/ibio-to-participate-in-the-8th-annual-evercore-healthcare-conference Mon, 24 Nov 25 16:15:00 -0500 https://ir.ibioinc.com/news-events/press-releases/detail/251/ibio-to-participate-in-the-8th-annual-evercore-healthcare-conference https://ir.ibioinc.com/news-events/press-releases/detail/250/ibio-reports-q1-fiscal-year-2026-financial-results-and-provides-corporate-update Wed, 12 Nov 25 16:01:00 -0500 https://ir.ibioinc.com/news-events/press-releases/detail/250/ibio-reports-q1-fiscal-year-2026-financial-results-and-provides-corporate-update https://ir.ibioinc.com/news-events/press-releases/detail/249/ibio-unveils-new-non-human-primate-data-on-ibio-610-an-activin-e-antibody-with-strong-therapeutic-potential-for-fat-selective-weight-loss-and-weight-maintenance Thu, 30 Oct 25 07:00:00 -0400 https://ir.ibioinc.com/news-events/press-releases/detail/249/ibio-unveils-new-non-human-primate-data-on-ibio-610-an-activin-e-antibody-with-strong-therapeutic-potential-for-fat-selective-weight-loss-and-weight-maintenance https://ir.ibioinc.com/news-events/press-releases/detail/248/ibio-to-participate-in-the-guggenheim-2nd-annual-healthcare-innovation-conference Thu, 23 Oct 25 07:00:00 -0400 https://ir.ibioinc.com/news-events/press-releases/detail/248/ibio-to-participate-in-the-guggenheim-2nd-annual-healthcare-innovation-conference